A California appeals court recently upheld a substantial multimillion dollar jury verdict awarded to a husband and wife who claimed that the defendant caused the husband’s rare and deadly form of cancer from exposure to asbestos containing products manufactured by the company. In their verdict in favor of the plaintiffs,…
Asbestos & Mesothelioma Law Blog
National Association of Distinguished Counsel Recognizes Attorney Michael Throneberry
Michael Throneberry, of Throneberry Law Group, has been selected to the 2021 list as a member of the Nation’s Top One Percent by the National Association of Distinguished Counsel. NADC is an organization dedicated to promoting the highest standards of legal excellence. Its mission is to objectively recognize the attorneys…
Norwegian biotech company’s immunotherapy drug shows promise for mesothelioma patients who undergo chemotherapy
A Norwegian biotechnology company recently announced that the 21-month followup data from its clinical stage immunotherapy trials revealed promising results for mesothelioma patients who are also undergoing chemotherapy to treat their rare and deadly form of cancer caused by asbestos exposure. The results of the study show that at least…
National Cancer Institute grants $2.5 million to study biological markers of mesothelioma
The National Cancer Institute recently awarded a $2.5 million grant to a Baylor University medical professor to develop clinical tests that would enable doctors to determine the likelihood of a patient responding to immunotherapy regimens before the patient receives the treatment, which would save certain patients from immune-related adverse events.…
Federal judge rules railroad worker’s mesothelioma lawsuit to be decided by jury
A federal judge in Maine recently denied a defendant’s request to have a mesothelioma cancer lawsuit tossed out on the grounds that the company could not have known about dangerous working conditions alleged by the victim, ruling that the question of foreseeability of injuries should be left for a jury…
Virtual mesothelioma trial underway in Washington state against Allied Mineral Products and Pryor-Giggey Co.
A virtual mesothelioma cancer trial recently got underway via Zoom in a Washington state court with each side presenting their opening arguments to the 16 person jury in Seattle. King County, Wash., is one of the most active jurisdictions in the country when it comes to virtual hearings during coronavirus…
New York City Court Allows Widow’s Mesothelioma Cancer Lawsuit to Proceed Against Port Authority
A New York City court recently struck down a defendant’s attempt in a mesothelioma cancer lawsuit to have the case thrown out on summary judgment, thus allowing the case to proceed on to trial and allow the victim’s widow to pursue justice on behalf of her deceased husband. The three-judge…
New Jersey Supreme Court Allows Talcum Powder Cancer Lawsuit to Proceed
The New Jersey state supreme court recently allowed a pair of talcum powder cancer lawsuits to proceed to trial. A lower court had overturned another judge’s decision to toss out the matter and effectively rule in favor of the defendant, Johnson & Johnson. Pharmaceutical and cosmetics giant Johnson & Johnson…
Johnson & Johnson Opposes Supplier’s Bankruptcy Plan to Settle Asbestos Cancer Lawsuits
Pharmaceutical and cosmetics giant Johnson & Johnson recently challenged the bankruptcy plan of its long-time talc supplier, Imerys Talc USA, asserting that the defunct American subsidiary’s plan to create a liability trust related to talcum powder asbestos cancer lawsuits is a way to immunize its French parent company. Imerys Talc…
Scottish Researchers Receive Grant to Develop Laser System Capable of Removing Mesothelioma Tumors
Researchers at a Scottish university are developing a new laser system that will help physicians distinguish between cancer tumor cells and healthy tissues, and allow them to remove the cancerous cells while leaving healthy surrounding tissue intact. To help further this research, the UK’s Engineering and Physical Sciences Research Council…